Necrotizing of Cancer Cells is Possible through Drug Designing and Development-Juniper Publishers
Novel Approaches in Drug Designing & Development (NAPDD)
The dictionary definition of "necrotizing” is causing
 or undergoing necrosis, a word said to have been first used in 1899. 
Historically, even before 1899, medical men and even cancer quacks had 
attempted to cure cancer with drugs. Nowadays, this is being 
intensified. Therefore, a personal hypothesis is proposed here with 
direct appeal to the recondite researchers in the fruitful field of drug
 designing and development.
 Keywords: Cancer; Necrosis; Drug; Design; Thoracic duct; ResearchIntroduction
The Merriam-Webster's Collegiate Dictionary defines "necrotizing" as "causing or undergoing necrosis" [1].
 It went on to indicate that this word was first used in 1899. However, 
before that year, causing necrosis was broadly the intention of the 
medical masters faced with cancer cases [2]. Nowadays, there is the hot pursuit for cure, this being aided by the mounting monetary means [3]. In this context, there is the fruitful front, namely, developing new targets for cancer treatment [4,5]. It is necessary, therefore, to direct attention to the status of the thoracic duct itself with a hypothesis.
Hypothesis
Historical attention was drawn to the premier position of the Pathology Laboratory at the Glasgow Western Infirmary [6].
 As fate would have it, when the author trained there, he devised the 
Mono-Block Formalin-Method for investigating lung cancer [7].
 Therefore, the obtained 45cm long thoracic duct was coiled up in 
Swiss-roll fashion thereby facilitating its study in one microscope 
slide [8].
 There upon, both lively cancer cells and dying cancer cells became 
research worthy. Indeed, the conclusion was clear thus: "Necrosis of the
 cancer cells was apparent in 3 cases, but it was clear that this had 
occurred in association with large aggregates of the malignant cells and
 that among each aggregated cells red blood corpuscles abounded." In 
effect, an erythrocyte associated necrosis factor (EANF) materialized 
naturally [9].
Accordingly, the vista has been opened for the 
microenvironment of the thoracic duct to be used jointly by researchers 
in the fields of (a) drug development and (b) those capable of 
cannulating this duct [10] and viewing it with the intra-vital video microscope [11].
 Thereafter, there should be retrieval of the scientifically rich 
materials that pointedly embody necrosis. In conclusion, this hitherto 
hidden intrinsic Factor ought to surface from the recommended joint 
cooperative exercise. Furthermore, to confirm or confute the above 
hypothesis should resound profitably. In all probability, this envisaged
 breakthrough in target therapy could conduce to cancer cure.   
Comments
Post a Comment